Who Paid My Doc
Natalia Zagorski
Anatomic Pathology & Clinical Pathology Honolulu, HI Medical Doctor
NPI 1720283351 CMS profile 1289982
1301 Punchbowl St, Honolulu, HI 96813
General payments
$125
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Natalia Zagorski of Honolulu, HI is reported in the CMS Open Payments database as having received $125 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 56th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $125 | 1 |
Beside peers
- Natalia Zagorski
- Anatomic Pathology & Clinical Pathology median
- Middle half of Anatomic Pathology & Clinical Pathology
- National median
In program year 2025, general payments to Natalia Zagorski were reported at $0. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.
Show as a table
| Year | Natalia Zagorski | Anatomic Pathology & Clinical Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $65 | $22–$150 | $163 |
| 2020 | $0 | $44 | $19–$144 | $114 |
| 2021 | $0 | $42 | $19–$142 | $132 |
| 2022 | $0 | $54 | $20–$140 | $149 |
| 2023 | $125 | $60 | $23–$157 | $160 |
| 2024 | $0 | $51 | $23–$145 | $164 |
| 2025 | $0 | $51 | $24–$149 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 30 billing codesPaid by Medicare
$68,439
Medicare patients
803
Services billed
2,285
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 39% | |
| Diabetes | 37% | |
| Chronic kidney disease | 29% | |
| Ischemic heart disease | 26% | |
| Cancer | 22% | |
| Osteoporosis | 20% | |
| Atrial fibrillation | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Anatomic Pathology & Clinical Pathology in Hawaii
Christopher Lum
Anatomic Pathology & Clinical Pathology · Honolulu, HI
Stella Wenceslao
Anatomic Pathology & Clinical Pathology · Honolulu, HI
Lisa Kim
Anatomic Pathology & Clinical Pathology · Honolulu, HI
Owen Chan
Anatomic Pathology & Clinical Pathology · Aiea, HI
David Peterson
Anatomic Pathology & Clinical Pathology · Tamc, HI
Todd Nishimoto
Anatomic Pathology & Clinical Pathology · Honolulu, HI
Related records
Anatomic Pathology & Clinical Pathology in Hawaii
Practitioners in the same specialty and state, ranked by reported value.
All Anatomic Pathology & Clinical Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Hawaii
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.